Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Gundersen

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Journal of Steroid Biochemistry|June 22, 1990
Toremifene, a new antiestrogenic compound in the treatment of metastatic mammary cancer. A phase II studyS Gundersen
Cancer|October 15, 1989
Interferon in combination with vinblastine in advanced malignant melanoma. A phase I-II studyS Gundersen, A Flokkmann
International Journal of Cancer|April 15, 1979
Treatment of micrometastases from Lewis lung carcinoma with abrin and cyclophosphamide, given singly and in combinationS Gundersen, O Fodstad
Scandinavian Journal of Haematology|September 1, 1979
Factors interfering with the cell morphology in smearsI Talstad, J S Gundersen
Cancer Treatment Reports|August 1, 1986
Radiation in combination with intra-arterial infusion therapy with dacarbazine for metastatic malignant melanoma localized to a lower extremityS Gundersen, B Hager, J Tausjø
European Journal of Cancer & Clinical Oncology|August 1, 1989
Regression analyses of prognostic factors in metastatic malignant melanomaK Heimdal, E Hannisdal, S Gundersen
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Prognostic factors for glioblastoma multiforme--development of a prognostic indexS Gundersen, K Lote, E Hannisdal
Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section C, Immunology|April 1, 1983
Purification and characterization of a mouse serum protein with growth inhibitory properties in vitro against tumor cell linesS Gundersen, E Paus, S Funderud
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 20, 1997
[Check up of breast cancer stages 1 and 2]S Gundersen, S Kvaløy, E Hannisdal
British Journal of Cancer|April 1, 1987
Mitozolomide (NSC 353451), a new active drug in the treatment of malignant melanoma. Phase II trial in patients with advanced diseaseS Gundersen, S Aamdal, O Fodstad
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Journal of Steroid Biochemistry|June 22, 1990
Toremifene, a new antiestrogenic compound in the treatment of metastatic mammary cancer. A phase II studyS Gundersen
Cancer|October 15, 1989
Interferon in combination with vinblastine in advanced malignant melanoma. A phase I-II studyS Gundersen, A Flokkmann
International Journal of Cancer|April 15, 1979
Treatment of micrometastases from Lewis lung carcinoma with abrin and cyclophosphamide, given singly and in combinationS Gundersen, O Fodstad
Scandinavian Journal of Haematology|September 1, 1979
Factors interfering with the cell morphology in smearsI Talstad, J S Gundersen
Cancer Treatment Reports|August 1, 1986
Radiation in combination with intra-arterial infusion therapy with dacarbazine for metastatic malignant melanoma localized to a lower extremityS Gundersen, B Hager, J Tausjø
European Journal of Cancer & Clinical Oncology|August 1, 1989
Regression analyses of prognostic factors in metastatic malignant melanomaK Heimdal, E Hannisdal, S Gundersen
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Prognostic factors for glioblastoma multiforme--development of a prognostic indexS Gundersen, K Lote, E Hannisdal
Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section C, Immunology|April 1, 1983
Purification and characterization of a mouse serum protein with growth inhibitory properties in vitro against tumor cell linesS Gundersen, E Paus, S Funderud
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 20, 1997
[Check up of breast cancer stages 1 and 2]S Gundersen, S Kvaløy, E Hannisdal
British Journal of Cancer|April 1, 1987
Mitozolomide (NSC 353451), a new active drug in the treatment of malignant melanoma. Phase II trial in patients with advanced diseaseS Gundersen, S Aamdal, O Fodstad
Pageof 7